CA
NZ
UK
AU
IND
US
NEKTAR THERAPEUTICS has disclosed the vesting of stock options for its President and CEO, Robin Howard W. This development is significant as it reflects the company's ongoing performance-based compensation strategy. Investors may find this information relevant as it pertains to executive incentives and potential …
Nektar Therapeutics has announced the vesting of stock options held by Chief R&D Officer Jonathan Zalevsky, a development that may interest investors tracking executive compensation and performance incentives. The stock options were granted under the company's 2017 Amended and Restated Performance Incentive Plan, reflecting …
Heartflow, Inc. has disclosed a recent transaction involving its Director Timothy Barabe, who reported changes in his beneficial ownership of the company's stock. This update is significant for investors as it reflects insider activity that can influence perceptions of the company's performance and future …
First Interstate Bancsystem Inc. has reported a significant acquisition of shares by its director, Brian Kevin Turner. The transaction took place on July 22, 2026, and highlights ongoing investment by key management, which may be of interest to investors monitoring insider activities.
First Interstate Bancsystem, Inc. recently reported a significant acquisition of shares by its director, Matthew John Ritter. This development, disclosed on July 24, 2026, highlights Ritter's ongoing investment in the company, which may be of interest to current and potential investors. The transaction reflects …
Savara Inc. has disclosed a recent transaction involving its Chief Financial and Operating Officer, Robert Lutz, who acquired a substantial number of stock options and restricted stock units. This acquisition is noteworthy as it reflects the confidence of the company’s leadership in its future …
Westamerica Bancorporation has disclosed a significant change in ownership by its Senior Vice President and Risk Officer, Curtis Belton. The announcement details the acquisition of shares and options, which may be of interest to investors monitoring insider activities and stock performance. This update highlights …
In a recent disclosure, MetLife Investment Management reported its involvement with the DNP Select Income Fund Inc. The investment firm acquired substantial amounts of the 3.00% Series B Senior Secured Notes due July 22, 2026. The transactions were executed on the maturity date of …
Immunovant, Inc. has reported a transaction involving its Chief Technology Officer, Jay Stout, who sold shares to cover tax withholding obligations after the vesting of restricted stock units. This development is significant for investors as it highlights the company's approach to employee compensation and …
Immunovant, Inc. recently disclosed a stock transaction involving its Chief Financial Officer, Tiago Girao. The transaction, which occurred on July 23, 2026, was executed to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs). This development is significant for investors …
Please wait processing your request...